Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 55 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9949962

    Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  2. US 9950044

    Treatment of pulmonary vascular remodeling with neprilysin

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  3. US 9943594

    Methods for the treatment of rheumatoid arthritis

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  4. US 9944918

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  5. US 9944603

    Compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  6. US 9937141

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  7. US 9938344

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  8. US 9937159

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Lutonix, Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  9. US 9937217

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  10. US 9937228

    Treatment of myocardial infarction by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  11. US 9926315

    Triazolopyridine compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  12. US 9920378

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  13. US 9919058

    Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  14. US 9918968

    Rapamycin analogs targeting proteasome function in the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  15. US 9913841

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

  16. US 9901580

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    O.D. Ocular Discovery Ltd. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  17. US 9902769

    Treatment of dermatological pathologies

    XBIOTECH INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  18. US 9901619

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  19. US 9896532

    Deactivation of urushiol and method of treatment and prevention of contact dermatitis

    The Regents of the University of California · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  20. US 9896445

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Ansana BioSciences, LLC · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  21. US 9895413

    Protection against and treatment of ionizing radiation

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  22. US 9890379

    Treatment of genetic disorders associated with DNA repeat instability

    BIOMARIN TECHNOLOGIES B.V. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  23. US 9890213

    Methods for the treatment of B cell-mediated inflammatory diseases

    VACCINEX, INC. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  24. US 9884096

    Compositions and methods related to graft versus host disease and treatments thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.